• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Temporary ventricular assist device implantation by sternotomy-avoiding technique for bridge-to-decision therapy: a comparison with conventional implantation.

作者信息

Akiyama Masatoshi, Sasaki Konosuke, Kawatsu Satoshi, Suzuki Yusuke, Suzuki Tomoyuki, Yoshioka Ichiro, Takahashi Goro, Kumagai Kiichiro, Adachi Osamu, Saiki Yoshikatsu

机构信息

Division of Cardiovascular Surgery, Tohoku University Graduate School of Medicine, 1-1Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.

出版信息

Gen Thorac Cardiovasc Surg. 2020 Mar;68(3):240-247. doi: 10.1007/s11748-019-01185-5. Epub 2019 Aug 1.

DOI:10.1007/s11748-019-01185-5
PMID:31372932
Abstract

OBJECTIVE

Temporary ventricular assist device (VAD) is a commonly used therapeutic option for cardiogenic shock. Patients requiring this treatment are often critical, and clinical outcomes remain unsatisfactory. This study evaluated the feasibility and efficacy of a sternotomy-avoiding technique for temporary VAD implantation to improve patient outcomes.

METHODS

Between December 2012 and November 2018, seven patients underwent temporary VAD implantation by sternotomy-avoiding technique (SA group) and eight by median sternotomy technique (MS group). Pre- and intraoperative characteristics, postoperative 7-day hemodynamic parameters, 30-day mortality, and adverse events were compared between the groups.

RESULTS

More than 50% of the patients were mechanically supported before temporary VAD implantation. Cardiopulmonary bypass time was significantly shorter in the SA than in the MS group (84 min vs 215 min; p = 0.011); surgical time tended to be shorter in the SA group (385 min vs 461 min; p = 0.064). Pump index, cardiac index, mixed venous oxygen saturation, and central venous pressure did not differ significantly during the first seven days of support. The 30-day incidence of any adverse event was not significantly different between the groups. No patients in the SA group needed re-exploration for surgical bleeding. Thirty-day all-cause mortality rates were 29% in the SA group and 0% in the MS group (p = 0.11).

CONCLUSIONS

The sternotomy-avoiding and conventional techniques resulted in comparable short-term hemodynamic support. The sternotomy-avoiding technique was associated with a potential reduction in risk of re-exploration for bleeding. These results support the usefulness of the sternotomy-avoiding procedure for selected patients.

摘要

相似文献

1
Temporary ventricular assist device implantation by sternotomy-avoiding technique for bridge-to-decision therapy: a comparison with conventional implantation.
Gen Thorac Cardiovasc Surg. 2020 Mar;68(3):240-247. doi: 10.1007/s11748-019-01185-5. Epub 2019 Aug 1.
2
Minimally invasive CentriMag ventricular assist device support integrated with extracorporeal membrane oxygenation in cardiogenic shock patients: a comparison with conventional CentriMag biventricular support configuration.微创 CentriMag 心室辅助装置与体外膜肺氧合联合应用于心源性休克患者:与传统 CentriMag 双心室支持配置的比较。
Eur J Cardiothorac Surg. 2017 Dec 1;52(6):1055-1061. doi: 10.1093/ejcts/ezx189.
3
Novel minimally invasive surgical approach using an external ventricular assist device and extracorporeal membrane oxygenation in refractory cardiogenic shock.在难治性心源性休克中使用体外心室辅助装置和体外膜肺氧合的新型微创手术方法。
Eur J Cardiothorac Surg. 2017 Mar 1;51(3):591-596. doi: 10.1093/ejcts/ezw349.
4
[Preliminary Results with Implantation of Extracorporeal Ventricular Assist System without Sternotomy Incision].[无胸骨切开术植入体外心室辅助系统的初步结果]
Kyobu Geka. 2018 Jul;71(7):519-523.
5
Bridge-to-decision therapy with a continuous-flow external ventricular assist device in refractory cardiogenic shock of various causes.在各种病因所致难治性心源性休克中使用连续流体外心室辅助装置进行桥接决策治疗。
Circ Heart Fail. 2014 Sep;7(5):799-806. doi: 10.1161/CIRCHEARTFAILURE.113.000271. Epub 2014 Jul 15.
6
The TandemHeart as a bridge to a long-term axial-flow left ventricular assist device (bridge to bridge).串联式人工心脏作为通向长期轴流左心室辅助装置的桥梁(桥接至桥接)。
Tex Heart Inst J. 2008;35(2):125-9.
7
Single center outcomes after temporary mechanical circulatory assist device prior to Heartmate 3 implantation - a retrospective cohort study.在植入 Heartmate 3 之前使用临时机械循环辅助装置的单中心结局 - 一项回顾性队列研究。
Scand Cardiovasc J. 2024 Dec;58(1):2353066. doi: 10.1080/14017431.2024.2353066. Epub 2024 Jul 4.
8
Pharmacological criteria for ventricular assist device insertion following postcardiotomy shock: experience with the Abiomed BVS system.心脏术后休克后植入心室辅助装置的药理学标准:Abiomed BVS系统的经验
J Card Surg. 1999 Jul-Aug;14(4):288-93. doi: 10.1111/j.1540-8191.1999.tb00996.x.
9
Short-term ventricular assist device as a bridge to decision in cardiogenic shock: is it a justified strategy?短期心室辅助装置作为心源性休克决策的桥梁:这是一种合理的策略吗?
Int J Artif Organs. 2016 May 16;39(3):0. doi: 10.5301/ijao.5000488. Epub 2016 May 11.
10
Assessment of Safety and Effectiveness of the Extracorporeal Continuous-Flow Ventricular Assist Device (BR16010) Use as a Bridge-to-Decision Therapy for Severe Heart Failure or Refractory Cardiogenic Shock: Study Protocol for Single-Arm Non-randomized, Uncontrolled, and Investigator-Initiated Clinical Trial.体外连续流心室辅助装置(BR16010)作为严重心力衰竭或难治性心源性休克桥接决策治疗的安全性和有效性评估:单臂非随机、非对照、研究者发起的临床试验研究方案。
Cardiovasc Drugs Ther. 2018 Aug;32(4):373-379. doi: 10.1007/s10557-018-6796-8.

本文引用的文献

1
The role of different mechanical circulatory support devices and their timing of implantation on myocardial damage and mid-term recovery in acute myocardial infarction related cardiogenic shock.不同机械循环支持装置的作用及其植入时机对急性心肌梗死相关心源性休克心肌损伤和中期恢复的影响。
J Interv Cardiol. 2018 Dec;31(6):717-724. doi: 10.1111/joic.12569. Epub 2018 Nov 20.
2
Minimally Invasive Left Ventricular Assist Device Implantation: A Comparative Study.微创左心室辅助装置植入术:一项对比研究。
Artif Organs. 2018 Dec;42(12):1125-1131. doi: 10.1111/aor.13269. Epub 2018 Nov 15.
3
Is it Possible to Implant HeartMate 3 Less Invasively? New Pump, New Approach.
能否以微创方式植入HeartMate 3?新型泵,新方法。
Artif Organs. 2018 Dec;42(12):1132-1138. doi: 10.1111/aor.13289. Epub 2018 Nov 4.
4
Minimally Invasive Implantation of Continuous Flow Left Ventricular Assist Devices: The Evolution of Surgical Techniques in a Single-Center Experience.连续流左心室辅助装置的微创植入:单中心经验中手术技术的演变
Artif Organs. 2019 Mar;43(3):E41-E52. doi: 10.1111/aor.13339. Epub 2018 Oct 28.
5
Minimally invasive surgery improves outcome of left ventricular assist device surgery in cardiogenic shock.微创手术改善心源性休克患者左心室辅助装置手术的预后。
J Thorac Dis. 2018 Jun;10(Suppl 15):S1696-S1702. doi: 10.21037/jtd.2018.01.27.
6
Comparison of temporary ventricular assist devices and extracorporeal life support in post-cardiotomy cardiogenic shock.心脏术后心源性休克中临时心室辅助装置与体外生命支持的比较
Interact Cardiovasc Thorac Surg. 2018 Dec 1;27(6):863-869. doi: 10.1093/icvts/ivy185.
7
A continuous-flow external ventricular assist device for cardiogenic shock: Evolution over 10 years.一种用于心源性休克的连续流体外心室辅助装置:10 年来的发展演变。
J Thorac Cardiovasc Surg. 2018 Jul;156(1):157-165.e1. doi: 10.1016/j.jtcvs.2017.12.148. Epub 2018 Feb 13.
8
Clinical Outcomes of Advanced Heart Failure Patients with Cardiogenic Shock Treated with Temporary Circulatory Support Before Durable LVAD Implant.在植入耐用左心室辅助装置(LVAD)之前接受临时循环支持治疗的晚期心力衰竭合并心源性休克患者的临床结局
ASAIO J. 2016 Jan-Feb;62(1):20-7. doi: 10.1097/MAT.0000000000000309.
9
Left ventricular assist device outflow graft: alternative sites.左心室辅助装置流出移植物:替代部位。
Ann Cardiothorac Surg. 2014 Sep;3(5):541-5. doi: 10.3978/j.issn.2225-319X.2014.09.03.
10
Clinical variability within the INTERMACS 1 profile: implications for treatment options.INTERMACS 1型患者的临床变异性:对治疗选择的影响。
Curr Opin Cardiol. 2014 May;29(3):244-9. doi: 10.1097/HCO.0000000000000066.